Combihale FF 250 Inhaler

Drug | Inhale

Maintenance treatment of asthma and COPD to reduce symptoms such as wheeze, breathlessness, chest tightness and to prevent exacerbations.

Fluticasone furoate is an inhaled corticosteroid that reduces airway inflammation and hyperresponsiveness. Vilanterol is a long-acting beta2-agonist that relaxes bronchial smooth muscle to keep airways open for prolonged symptom control.

Use by inhalation exactly as prescribed, usually once daily at the same time each day. Not for sudden asthma attacks; keep a rescue inhaler (e.g., salbutamol). Rinse mouth/gargle after each use to reduce oral thrush; ensure correct inhaler technique.

Hoarseness, throat irritation, cough, headache, oral thrush (candidiasis), palpitations, tremor

Not a rescue medicine for acute bronchospasm. Increased risk of pneumonia in COPD; monitor for fever, increased sputum or worsening breathlessness. Use with caution in heart rhythm disorders, hypertension, diabetes, hyperthyroidism, glaucoma, and infections (including TB). Do not stop abruptly without medical advice.

Strong CYP3A4 inhibitors (e.g., ketoconazole, ritonavir) increase steroid exposure; other beta-agonists, MAO inhibitors/TCAs (cardiac effects); beta-blockers may reduce effect; diuretics can increase risk of hypokalemia with LABA.

Store below 25°C, keep dry and protected from moisture/heat. Keep device closed when not in use.

Relvar Ellipta 200/25, Trelegy/ICS-LABA equivalents (doctor dependent), Seroflo/Foracort (different molecules), Budamate, Symbicort (different molecules)